tykhr
sign in
free sign up
Reata Pharmaceuticals Inc
Biotechnology
Healthcare
RETA
41.51 M shares
NASDAQ US
traded
25 Sep 2023
listed
yes
open
172.34
52 week high
172.36
high
172.46
52 week low
22.12
low
172.32
growth
624.81 %
previous Close
172.17
P/E ratio
37
market cap
6.36 B
div yield
0
usd
Jun 2023
qoq
revenue
22.75 M
11.00 %
net incoming
193 M
266.21 %
eps
4.65 %
248.09 %
eps surprise
261.46 %
net profit margin
848.49 %
60395.00 %
operating incoming
193 M
274.73 %
net change in cash
-36.10 M
-184.68 %
cash on hand
48.84 M
-42.50 %
cost of revenue
846 K
0.00 %
top